Related Experiment Videos
The endometrium and hormonal contraceptives
G Benagiano1, A Pera, F M Primiero
1Istituto Superiore di Sanità and Ist Institute of Obstetrics & Gynaecology, University la Sapienza, Rome, Italy.
Human Reproduction (Oxford, England)
|August 6, 2000
Summary
Contraceptive progestogens impact the endometrium and menstrual bleeding. Effects vary based on administration route, dose, and estrogen priming, with injectable forms causing maximal bleeding disruption.
Area of Science:
- Reproductive Endocrinology
- Gynecology
Background:
- Contraceptive progestogens exert diverse effects on the endometrium.
- These effects are contingent upon estrogen priming, administration route, and dosage.
Purpose of the Study:
- To elucidate the endometrial and menstrual pattern alterations induced by contraceptive progestogens.
- To differentiate effects based on administration route (oral, intramuscular, intrauterine) and formulation.
Main Methods:
- Review of existing literature on progestogen pharmacology and endometrial response.
- Analysis of studies comparing oral, intramuscular, and intrauterine progestogen delivery systems.
Main Results:
- Oral progestogens typically induce endometrial decidualization and stromal changes.
- Intramuscular or intrauterine progestogen delivery is associated with endometrial atrophy.
- All contraceptive progestogens, when used alone, disrupt menstrual bleeding patterns.
- Injectable, long-acting progestogens (e.g., depot-medroxyprogesterone acetate) cause the most significant menstrual irregularities.
Conclusions:
- Progestogen-induced endometrial changes and bleeding patterns are highly dependent on administration method and dose.
- Understanding these variations is crucial for optimizing contraceptive efficacy and managing side effects.